Antithyroid Drug Use in Pregnancy and Birth Defects: Why Some Studies Find Clear Associations, and Some Studies Report None

Abstract excerpt

BACKGROUND: Rare cases of birth defects after the use of methimazole (MMI) or carbimazole to treat hyperthyroidism in early pregnancy have been reported since 1972, whereas propylthiouracil (PTU) has not been considered teratogenic. Recently, two studies reported birth defects after the use of MMI in early pregnancy to affect 2-4% of exposed children, and one study also found birth defects after the use of PTU....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Parathyroid Disorders and Treatments
• Share to Pregnancy and Medication Impact
• Share to Thyroid Disorders and Treatments